OBJECTIVES: Depression is associated with increased physical morbidity and overall mortality. As less is known about how much depression increases the 10-year risk for fatal and nonfatal cardiovascular (CV) events, we evaluated the cross-sectional risk with two well-characterized risk functions measuring CV mortality and total CV event risk. METHODS: The prevalence of increased depressive symptoms was measured with the Beck Depression Inventory (BDI), and the SCORE and Framingham risk functions were calculated in a middle-aged population-based sample (N=923). For metabolic syndrome (MetS), the modified National Cholesterol Education Program-Adult Treatment Panel III criteria were employed. RESULTS: Depressive symptoms were associated with increased CV mortality and morbidity risk in men: OR for SCORE 2.9; 95%CI 1.4-5.7 and OR for Framingham function 2.2 (95%CI 1.1-4.2). In women, the corresponding figures were 1.4 (95%CI 0.3-6.9) and 1.3 (95%CI 0.7-2.6). The BDI scores showed significant correlations with SCORE (r=0.18 for men, P < 0.001; and r=0.14 for women, P=0.002), and Framingham function (for men r=0.16, P < 0.001; and for women r=0.13, P=0.005). CONCLUSIONS: Our results suggest that screening and effective treatment of depression are important in the primary and secondary prevention of cardiovascular events, especially in males.
OBJECTIVES:Depression is associated with increased physical morbidity and overall mortality. As less is known about how much depression increases the 10-year risk for fatal and nonfatal cardiovascular (CV) events, we evaluated the cross-sectional risk with two well-characterized risk functions measuring CV mortality and total CV event risk. METHODS: The prevalence of increased depressive symptoms was measured with the Beck Depression Inventory (BDI), and the SCORE and Framingham risk functions were calculated in a middle-aged population-based sample (N=923). For metabolic syndrome (MetS), the modified National Cholesterol Education Program-Adult Treatment Panel III criteria were employed. RESULTS:Depressive symptoms were associated with increased CV mortality and morbidity risk in men: OR for SCORE 2.9; 95%CI 1.4-5.7 and OR for Framingham function 2.2 (95%CI 1.1-4.2). In women, the corresponding figures were 1.4 (95%CI 0.3-6.9) and 1.3 (95%CI 0.7-2.6). The BDI scores showed significant correlations with SCORE (r=0.18 for men, P < 0.001; and r=0.14 for women, P=0.002), and Framingham function (for men r=0.16, P < 0.001; and for women r=0.13, P=0.005). CONCLUSIONS: Our results suggest that screening and effective treatment of depression are important in the primary and secondary prevention of cardiovascular events, especially in males.
Authors: Chad D Rethorst; Charles C South; A John Rush; Tracy L Greer; Madhukar H Trivedi Journal: Depress Anxiety Date: 2017-07-03 Impact factor: 6.505
Authors: Joanna Rees; Claus C Christophersen; Joshua R Lewis; Johnny Lo; Ros Sambell; Leesa Costello; Cailyn Walker; Matt F Byrne; Mary C Boyce; Robert U Newton; Amanda Devine Journal: BMC Public Health Date: 2020-06-30 Impact factor: 3.295
Authors: Adem Atici; Ramazan Asoglu; Ahmet Demirkiran; Nail Guven Serbest; Baris Emektas; Remzi Sarikaya; Ipek Yeldan; Ahmet Kaya Bilge Journal: North Clin Istanb Date: 2020-02-10
Authors: Susanna M Kuneinen; Johan G Eriksson; Hannu Kautiainen; Mikael O Ekblad; Päivi E Korhonen Journal: Scand J Prim Health Care Date: 2021-06-07 Impact factor: 2.581
Authors: Jussi Seppälä; Hannu Koponen; Hannu Kautiainen; Johan G Eriksson; Olli Kampman; Jaana Leiviskä; Satu Männistö; Pekka Mäntyselkä; Heikki Oksa; Yrjö Ovaskainen; Merja Viikki; Mauno Vanhala; Jussi Seppälä Journal: BMC Psychiatry Date: 2013-05-24 Impact factor: 3.630